CTOs on the Move

Encompass Health

www.encompasshealth.com

 
Encompass Health Corporation is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with over 165 facilities across the country and Puerto Rico. Founded in 1984 and rebranded in 2019, the company serves approximately 225,000 patients each year, focusing on intensive rehabilitation programs supported by 24/7 medical oversight. The company specializes in inpatient rehabilitation for patients recovering from surgeries, illnesses, and injuries. Encompass Health offers individualized care plans and employs multidisciplinary teams, including physical therapists, nurses, and physicians, to provide three hours of daily therapy, five days a week. Their approach emphasizes regaining independence through structured therapy ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

Collins + Collins LLP

Collins + Collins LLP is a law firm based in Pasadena, California, founded in 1964 by James and John Collins. Initially focused on serving public entities and private clients in Los Angeles County, the firm has grown to include six offices across California and Nevada. A significant merger in the 1980s expanded its practice areas and strategic locations. The firm provides a wide range of legal services, including litigation and transactional matters. With expertise in over eleven legal specialties, Collins + Collins LLP addresses disputes, transactions, and compliance issues for a diverse clientele, including corporations, partnerships, public entities, and professionals. The firm emphasizes client satisfaction and combines the resources of a large firm with the personalized attention of a smaller practice, ensuring tailored legal counsel and representation.

Publishers Design and Prod Svcs

Publishers Design and Prod Svcs is a Sagamore Beach, MA-based company in the Business Services sector.

Ensho Therapeutics

Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.

Sinopac Securities

Sinopac Securities is a San Francisco, CA-based company in the Business Services sector.

Talespin ✈️

Talespin is building the XR platform to power knowledge transfer and skill alignment for the future of employment